{"id":"W4309247748","doi":"10.1002/ejhf.2738","title":"<scp>Health‐related</scp> quality of life outcomes in <scp>PARAGON‐HF</scp>","year":2022,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Respicardia; Sanofi Pasteur; National Institutes of Health; Servier; Moderna; Sarepta Therapeutics; Alnylam Pharmaceuticals; Cytokinetics; American Regent; Sanofi; MyoKardia; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; AstraZeneca; Eli Lilly and Company; Daiichi-Sankyo; Amgen","keywords":"Medicine; Sacubitril; Valsartan; Sacubitril, Valsartan; Confidence interval; Internal medicine; Odds ratio; Ejection fraction; Quality of life (healthcare); Heart failure; Randomization; Randomized controlled trial; Minimal clinically important difference; Cardiology; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001349364,0.0002159284,0.0005291667,0.0001413295,0.0001494443,0.0003618526,0.0001204263,0.0002079531,0.001622604],"category_scores_gemma":[0.0009073119,0.00006376666,0.0006043694,0.0002324489,0.0002135778,0.0001817408,0.0003301493,0.000362273,0.0000967442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001974753,"about_ca_system_score_gemma":0.000416425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007789325,"about_ca_topic_score_gemma":0.00159569,"domain_scores_codex":[0.9995561,0.0002385766,0.00003809658,0.00005154895,0.00006694874,0.00004867898],"domain_scores_gemma":[0.9994069,0.0001290568,0.0002237153,0.00003849038,0.00005777771,0.0001440381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.309595,0.004922273,0.435168,0.001865488,0.0043711,0.0002407406,0.0001607303,0.002604138,0.00880448,0.0004587008,0.005354227,0.2264551],"study_design_scores_gemma":[0.03180171,0.06975397,0.8885269,0.0001738798,0.001980847,0.0005559184,0.00009441267,0.001854945,0.002269303,0.0003253085,0.002641106,0.00002167314],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966847,0.00188786,0.0000974358,0.0001307887,0.00002197525,0.00005587962,0.0003740357,0.000007689205,0.0007396058],"genre_scores_gemma":[0.9986099,0.0002809005,0.0001944767,0.00007209053,0.00003563177,0.00005813296,0.0006025363,7.507718e-7,0.0001455577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001622604,"threshold_uncertainty_score":0.007136166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0243482616257864,"score_gpt":0.2768634082248604,"score_spread":0.252515146599074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}